Recent Updates
Recently added Catalysts
NUS Neutral Sentiment

CORRECTING and REPLACING Nu Skin Enterprises Reports Third Quarter Earnings

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nu Skin Enterprises Inc. announced a correction to its previous earnings release. The updated version includes adjustments to the valuation allowance on deferred tax assets and the reconciliation of earnings per share. The company reported third quarter revenue figures, but specific details were not provided in the article.

Market Sentiment Analysis

Full Press Release Details

PROVO, Utah--(BUSINESS WIRE)--Please replace the release with the following corrected version, which corrects Nine Months Ended September 2026 "Impact of valuation allowance on deferred tax assets" and "Adjusted net income" in the "Reconciliation of Earnings Per Share Excluding Impact of Certain Charges to GAAP Earnings Per Share" table. The updated release reads: NU SKIN ENTERPRISES REPORTS THIRD QUARTER EARNINGS Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within

Frequently Asked Questions

What correction was made to Nu Skin's earnings report?

The correction addressed the valuation allowance on deferred tax assets.

What does the updated earnings report include?

It includes adjustments to earnings per share reconciliation.

When was the earnings report released?

The earnings report was released for the third quarter.

What ticker symbol is associated with Nu Skin?

Nu Skin operates under the ticker symbol NUS.

ShareAdd on Google
Tags: NUS Nu Skin Enterprises third quarter earnings financial report tax assets
Last updated: Nov 5, 2026

Biotech snapshot

Cash runway
$191M liquidity · $0M/mo burn
Low dilution risk